$31.49
Price
$3.9B
Market Cap
18.2
P/E Ratio
9.9
Forward P/E
$1.73
EPS (TTM)
—
Dividend Yield
$756M
Cash
$3M
Total Debt
122M
Shares Out
$19.05
$32.56
52-Week Range
Institutional Ownership of Catalyst Pharmaceuticals Inc
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| 210.2K | $7M | $23.93 | +31.62% |
Trading Activity for Catalyst Pharmaceuticals Inc
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2026-Q2 | |||||
| SELL | EXIT | — | — | — | |
| 2026-Q1 | |||||
| SELL | -74.9% | 844.9K | $21M | $23.93 | |
| BUY | NEW | 210.2K | $5M | $23.93 | |
| 2025-Q3 | |||||
| BUY | +24.2% | 3.4M | $66M | $20.40 | |
| 2025-Q2 | |||||
| BUY | +25.9% | 2.7M | $59M | $23.65 | |
| 2025-Q1 | |||||
| BUY | NEW | 2.2M | $52M | $22.58 | |
Insider Trading for Catalyst Pharmaceuticals Inc
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.